The Need for New Criteria to Define Disease Activity and Treatment Response Using Disease Activity Score (DAS)28-C-reactive Protein

Hae-Rim Kim

doi:10.4078/jrd.2016.23.5.277

Journal List > J Rheum Dis > v.23(5) > 1064277

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kim: The Need for New Criteria to Define Disease Activity and Treatment Response Using Disease Activity Score (DAS)28-C-reactive Protein

Editorial

J Rheum Dis 2016;23(5):277-278.

Published online: 31 October 2016

DOI: https://doi.org/10.4078/jrd.2016.23.5.277

The Need for New Criteria to Define Disease Activity and Treatment Response Using Disease Activity Score (DAS)28-C-reactive Protein

Hae-Rim Kim

Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea

Corresponding to: Hae-Rim Kim, Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea. E-mail: kimhaerim@kuh.ac.kr

Received 24 September 201626 September 2016 Accepted 26 September 2016

This is a Free Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

1. van der Heijde DM, van't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990; 49:916–20.

2. van der Heijde DM, van't Hof MA, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis. 1992; 51:177–81.

3. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38:44–8.

4. Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis. 2007; 66:1221–6.

5. Song GG, Lee LH. Comparison of disease activity score 28 using C-reactive protein and disease activity score 28 using erythrocyte sedimentation rate in assessing activity and treatment response in rheumatoid arthritis: a meta-analysis. J Rheum Dis. 2016; 23:241–9.

6. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004; 279:48487–90.

7. Henriquez-Camacho C, Losa J. Biomarkers for sepsis. Biomed Res Int. 2014; 2014; 547818.

8. Castrejón I, Ortiz AM, García-Vicuña R, Lopez-Bote JP, Humbría A, Carmona L, et al. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol. 2008; 26:769–75.

9. Son KM, Kim SY, Lee SH, Yang CM, Seo YI, Kim HA. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis. Int J Rheum Dis. 2015; DOI: DOI: 10.1111/1756-185X.12698.

10. Siemons L, Vonkeman HE, ten Klooster PM, van Riel PL, van de Laar MA. Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker. Clin Rheumatol. 2014; 33:783–9.

TOOLS

Similar articles